DEVELOPMENT AND VALIDATION OF METHOD OF QUANTITATIVE DETERMINATION OF RESIDUAL ORGANIC SOLVENTS IN INNOVATIVE ACTIVE PHARMACEUTICAL INGREDIENT WITH GC-FID

DEVELOPMENT AND VALIDATION OF METHOD OF QUANTITATIVE DETERMINATION OF RESIDUAL ORGANIC SOLVENTS IN INNOVATIVE ACTIVE PHARMACEUTICAL INGREDIENT WITH GC-FID

The aim of the study was to develop and validate a new method of quantitative determination of residual organic solvents in a substance A using GLC. Studies were carried out with gas chromatography with a flame ionization detector and sampling from the vapor phase. The effect of the polarity of the...

Full description

Bibliographic Details
Main Authors:	E. V. Butina, S. A. Zaitsev, A. V. Basevich
Format:	Article
Language:	Russian
Published:	LLC Center of Pharmaceutical Analytics (LLC «CPHA») 2019-01-01
Series:	Разработка и регистрация лекарственных средств
Subjects:	остаточные органические растворители валидация разработка методики активная фармацевтическая субстанция
Online Access:	https://www.pharmjournal.ru/jour/article/view/165

Similar Items

Development and Validation of Conditions for the Determination of Residual Organic Solvents – Acetic Acid in the Silver Salt Substance 4-[4-(atsetilaminosul'fonil)fenil]-6-(4-bromfenil)-5-(2-nitrofenil)-3,5-digidropirrolo[3,4-с]pirazol-3-ona
by: E. N. Lyust, et al.
Published: (2022-12-01)

Development and Validation of a Procedure for the Quantitative Determination of Residual Organic Solvents in Allergen Preparations by GC
by: R. A. Bubenchikov, et al.
Published: (2022-05-01)

EXPLORING OF ACID-BASIC PROPERTIES, DEVELOPMENT AND VALIDATION OF THE METHOD OF QUANTITATIVE DETERMINATION OF ORIGINAL PHARMACEUTICAL SUBSTANCE
by: G. M. Alekseeva, et al.
Published: (2019-02-01)

PROJECT-ORIENTED APPROACH TO FINISHED PHARMA PRODUCT DEVELOPMENT IN THE CONTEXT OF GENERIC POLYCOMPONENT DRUG CONTAINING AMOXYCILLIN AND CLAVULANIC ACID
by: Yu. V. Vlasenko
Published: (2019-01-01)

TECHNOLOGY OF OBTAINING POLYRIBOSYLRIBITOL PHOSPHATE AS AN ACTIVE PHARMACEUTICAL INGREDIENT FOR THE PRODUCTION OF POLYSACCHARIDE VACCINES
by: E. L. Salimova, et al.
Published: (2018-03-01)

DEVELOPMENT AND VALIDATION OF THE METHOD OF KINETIC EVALUATION OF MEDICAL SUBSTANCE TOPIRAMAT DISSOLUTION BY LASER DIFFRACTION OF LIGHT METHOD
by: E. V. Uspenskaya, et al.
Published: (2019-01-01)

Documentation of Pharmaceutical Development. Part 2. Quality System Documents
by: I. E. Smekhova, et al.
Published: (2021-05-01)

Standardization of the Pharmaceutical Substance of the Drug LCS-1208
by: E. V. Ignateva, et al.
Published: (2021-08-01)

The sodium 5-butyl-1,2-diphenyl-6-oxo-1,6-dihydropyrimidine-4-olate quantitative content determination in a standard sample
by: E. V. Kuvaeva, et al.
Published: (2021-12-01)

PHARMACEUTICAL DEVELOPMENT OF DRUGS FOR PEDIATRIC PRACTICE: FUNDAMENTAL BASES AND SPECIFIC FEATURES
by: I. A. Narkevich, et al.
Published: (2019-01-01)

THE USE OF THE IDEF0 STANDARD IN PREPARATION FOR PHARMACEUTICAL DEVELOPMENT
by: S. A. Rozhnova, et al.
Published: (2019-01-01)

Thin layer chromatography of some statins in aqueous organic mobile phases modified with buff er solutions
by: Sumina, Elena G., et al.
Published: (2023-03-01)

Documentation of Pharmaceutical Development. Part 1. Study of the Documentation of the Site
by: I. E. Smekhova, et al.
Published: (2021-02-01)

ANALYSIS OF THE SYSTEM ORGANIZATION OF PHARMACEUTICAL DRUG DEVELOPMENT
by: S. A. Rozhnova, et al.
Published: (2019-01-01)

PHARMACEUTICAL DEVELOPMENT OF FORMULATION BASED ON BIOPHARMACEUTICAL PREPARATIONS FOR GENE THERAPY
by: T. V. Budylskaya, et al.
Published: (2019-01-01)

ABNORMAL TOXICITY TEST VALIDATION FOR INSULIN SUBSTANCE STANDARDISATION
by: V. M. Kosman, et al.
Published: (2019-01-01)

STANDARDIZATION OF CATIONIC DERIVATIVE OF BAKTERIOPURPURINIMID AS PHARMACEUTICAL SUBSTANCE FOR ANTIMICROBIAL PHOTODYNAMIC THERAPYA
by: A. M. Frolova, et al.
Published: (2019-01-01)

Validation of Analytical Procedures: Graphic and Calculated Criteria for Assessment of Methods Linearity in Practice
by: N. A. Epshtein
Published: (2019-05-01)

ИЗУЧЕНИЕ ВОЗМОЖНОСТИ ПЕРЕРАБОТКИ ТОЛУОЛСОДЕРЖАЩИХ КУБОВЫХ ОСТАТКОВ В КОКСОХИМИЧЕСКОМ ПРОИЗВОДСТВЕ
by: Анна Павловна Банникова, et al.
Published: (2022-12-01)

Polymorphism: the influence on the quality of drugs and actual methods of analysis
by: G. N. Gildeeva
Published: (2018-05-01)

FEATURES OF QUALITY ASSESSMENT AND STANDARDIZATION PROSPECTS OF FATTY OILS AND OIL EXTRACTS FOR PHARMACEUTICAL PURPOSES (REVIEW)
by: E. V. Semina, et al.
Published: (2019-01-01)

TOXICOLOGICAL AND PHARMACOLOGICAL CHARACTERISTICS OF EXCIPIENTS OF DRUG PRODUCTS OF TORASEMIDE
by: D. Yu. Ivkin, et al.
Published: (2019-01-01)

Comparative Analysis of the QbD Approach in the Pharmaceutical Industry
by: S. A. Rozhnova, et al.
Published: (2019-11-01)

Labeling of Immunobiological Drugs, Produced by the Russian Research An-ti-Plague Institution "Microbe" of the Rospotrebnadzor (Review)
by: A. V. Komissarov, et al.
Published: (2021-08-01)

STUDY OF THE EFFECT OF STRUCTURE ON OCTANOL-WATER DISTRIBUTION OF 6-HYDROXYPYRIMIDINE-4-(<i>3H</i>)-ONES DERIVATIVES
by: A. E. Potapova, et al.
Published: (2019-01-01)

III International Scientific and Practical Conference «Harmonization of approaches to pharmaceutical development», Held on November 25, 2020
by: Article Editorial
Published: (2020-12-01)

ASSESSMENT OF THE RUSSIAN FEDERATION REQUIREMENT IN POTENT ANALGESICS
by: A. V. Sosnov, et al.
Published: (2019-01-01)

Relevant issues of testing quality of drugs in the form of tablets
by: E. L. Kovaleva, et al.
Published: (2018-02-01)

FORMATION OF REQUIREMENTS TO SPECIALIST-EXPLORER IN DEVELOPMENT OF RECEIPT OF NANOSTRUCTURED PHARMACEUTICALS
by: S. A. Kedik, et al.
Published: (2019-01-01)

VALIDATION OF CHROMATOGRAPHIC METHODS: ROBUSTNESS INVESTIGATION WITH USE OF EXPERIMENTAL DESIGN
by: N. A. Epshtein
Published: (2019-01-01)

PROBLEMS AND PROSPECTS OF PHARMACEUTICAL PREVENTION IN PROFESSIONAL DISEASES
by: Андрей Георгиевич Петров, et al.
Published: (2020-07-01)

BIOPHARMACEUTICAL CLASSIFICATIOM SYSTEM AS A TOOL FOR THE DEVELOPMENT OF DRUG FORMULATIONS AND THEIR DESIGNS
by: N. B. Demina
Published: (2019-01-01)

Application of Quality-by-Design Approach to Justify the Composition and Technology of Two-component Suppositories
by: I. E. Smekhova, et al.
Published: (2022-11-01)

REFERENCE STANDARDS OF ACTIVE INGREDIENTS OF POTENT ANALGESIC DRUGS
by: A. V. Sosnov, et al.
Published: (2019-01-01)

MODELING PROCESS OF PALLIATIVE PHARMACEUTICAL CARE AS A COMPONENT OF PHARMACEUTICAL SAFETY AT THE LOCAL LEVEL
by: I. A. Tueva, et al.
Published: (2018-07-01)

ABOUT STRESS EXPERIMENTS BY DEVELOPING / IMPROVING ANALYTICAL METHODS AND TECHNOLOGY OF DRUG SUBSTANCES AND MEDICINES
by: N. A. Epshtein
Published: (2019-01-01)

Optimization of the endodontic retreatment
by: Z. S. Khabadze, et al.
Published: (2020-04-01)

STUDY AND MODELING OF SOLVENT INFLUENCE ON ISOSALIPURPOSIDE EXTRACTION FROM HELICHRYSI ARENARII FLOWERS
by: N. N. Boyko, et al.
Published: (2018-09-01)

Development of UV-spectrophotometry Method of the Quantitative Determination of a New Substance Quinazoline-4(3h)-on Derivate
by: E. S. Mishchenko, et al.
Published: (2020-02-01)

Pharmaceutical Residual Solvent Analysis: A Comparison of GC-FID and SIFT-MS Performance
by: Mark J. Perkins, et al.
Published: (2023-06-01)